Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC [Phase 3]
A Phase 3 trial comparing vedolizumab monotherapy to combination therapy with tacrolimus in ulcerative colitis was terminated; results were …
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating adipose mesenchymal stem cells for ulcerative colitis; current status unknown.
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis. [Phase 3]
Extension study of Budesonide MMX 6 mg for maintenance of remission in Ulcerative Colitis completed.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M [Phase 2]
Phase 2a randomized trial of IBD98-M in ulcerative colitis completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease [Phase 1]
Phase I study of etrolizumab in pediatric patients with moderate-to-severe ulcerative colitis or Crohn's disease was terminated; results hav…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Phase II Study of HMPL-004 in Patients With Ulcerative Colitis [Phase 2]
Phase II study of HMPL-004 in ulcerative colitis has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis [Phase 3]
Phase 3 clinical trial evaluating FE 999315 in Japanese patients with mild to moderate active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-12Clinical Trial Update: A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)
Clinical trial evaluating disease control, treatment patterns, burden of disease, and quality of life in moderate to severe inflammatory bow…
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: GSK2982772 Study in Subjects With Ulcerative Colitis [Phase 2]
Phase 2 trial of GSK2982772 in ulcerative colitis completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis [Phase 1]
Phase I study of CT-P13 subcutaneous in active Crohn's disease and ulcerative colitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-29Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 study of mirikizumab in moderate to severe ulcerative colitis completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis [Phase 2]
Phase 2 trial of Kyowa Kirin's monoclonal antibody KHK4083 for moderate ulcerative colitis completed; results posted March 5, 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
A completed post-marketing study evaluating CT-P13 (infliximab) for standard of care treatment in inflammatory bowel diseases, including ulc…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 long-term safety trial of etrolizumab in moderate to severe ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: The Colitis Once Daily Asacol Study [Phase 3]
Phase 3 clinical trial update for Colitis Once Daily Asacol study (NCT00708656) in ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2) [Phase 3]
Phase 3 trial comparing LT-02 (phosphatidylcholine) to placebo and mesalamine for maintenance of remission in ulcerative colitis has complet…
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis [Phase 3]
Phase 3 trial update on vedolizumab subcutaneous maintenance therapy for ulcerative colitis reports efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis [Phase 3]
Phase 3 trial assessing safety and efficacy of MMX Mesalamine/Mesalazine in pediatric patients with mild to moderate ulcerative colitis has …
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis [Phase 3]
Phase 3 trial update for HMPL-004 maintenance treatment in mild to moderate ulcerative colitis; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Mercaptopurine Therapy in Ulcerative Colitis [Phase 3]
Phase 3 trial update on mercaptopurine therapy for ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis [Phase 3]
A Phase III trial of HMPL-004 in mild to moderate active ulcerative colitis was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
A Phase 3 study evaluating ustekinumab induction and maintenance therapy for moderately to severely active ulcerative colitis has completed …
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants
A completed clinical trial evaluating vedolizumab intravenous therapy for ulcerative colitis in Korean participants, with results posted in …
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis [Phase 3]
Phase 3 clinical trial updating mesalamine pellet formulation to maintain remission in mild to moderate ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis [Phase 3]
Phase 3 trial update for mesalamine pellet to maintain remission in mild to moderate ulcerative colitis has completed.